Form 4: Expensify Director Daniel Vidal Sells 20,000 Shares
SEC Form 4 Filing
Director Daniel Vidal sold 20,000 shares of Expensify, Inc. on March 15, 2024, at prices ranging from $1.95 to $2.05.
Summary
- On March 15, 2024, Daniel Vidal, a director of Expensify, Inc., sold 20,000 shares of Class A Common Stock.
- The sale was executed under a pre-arranged Rule 10b5-1 trading plan.
- The shares were sold at a weighted average price of $2, with individual transactions ranging from $1.95 to $2.05.
- Following the transaction, Vidal directly owns 129,727 shares of Expensify, Inc.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing regarding a director's stock sale. It doesn't inherently convey positive or negative sentiment, but the fact that a director is selling shares could be interpreted neutrally to slightly negatively depending on the context and the size of the sale relative to their holdings.
Industry Context
This filing is a routine disclosure of insider trading activity. It's important to monitor such filings to understand the sentiment of company insiders regarding the company's prospects.
Stakeholder Impact
- The sale of shares by a director could potentially influence investor sentiment, although the impact is likely to be minimal given the relatively small number of shares sold and the use of a pre-arranged trading plan.
Key Dates
| Date | Description |
|---|---|
| September 14, 2022 | Date of adoption of Rule 10b5-1 trading plan |
| December 15, 2023 | Date of amendment of Rule 10b5-1 trading plan |
| March 15, 2024 | Date of transaction (sale of shares) |
| March 19, 2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.